136 related articles for article (PubMed ID: 21918803)
21. Surgical resection of relapse may improve postrelapse survival of patients with localized osteosarcoma.
Wong KC; Lee V; Shing MM; Kumta S
Clin Orthop Relat Res; 2013 Mar; 471(3):814-9. PubMed ID: 22972657
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of conventional grade I chondrosarcoma of long bones.
Leerapun T; Hugate RR; Inwards CY; Scully SP; Sim FH
Clin Orthop Relat Res; 2007 Oct; 463():166-72. PubMed ID: 17632422
[TBL] [Abstract][Full Text] [Related]
23. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
24. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
[TBL] [Abstract][Full Text] [Related]
25. Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma.
Duchman KR; Lynch CF; Buckwalter JA; Miller BJ
Clin Orthop Relat Res; 2014 Aug; 472(8):2516-25. PubMed ID: 24706044
[TBL] [Abstract][Full Text] [Related]
26. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
27. Management and prognostic significance of pathological fractures through chondrosarcoma of the femur.
Albergo JI; Gaston CL; Jeys LM; Khajuria A; Carter SR; Tillman RM; Abudu AT; Grimer RJ
Int Orthop; 2015 May; 39(5):943-6. PubMed ID: 25711397
[TBL] [Abstract][Full Text] [Related]
28. Survival and prognostic factors in conventional central chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
BMC Cancer; 2018 Aug; 18(1):849. PubMed ID: 30143018
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of sinonasal chondrosarcoma in 47 cases].
Li WP; Lu HY; Wang H; Zhang HK; Liu Q; Sun XC; Hu L; Wang DH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):14-20. PubMed ID: 31954383
[No Abstract] [Full Text] [Related]
30. Proximal humerus chondrosarcoma.Long-term clinical and oncological outcomes.
Albergo JI; Farfalli Luis GL; Ayerza MA; Muscolo DL; Aponte-Tinao LA
Rev Esp Cir Ortop Traumatol (Engl Ed); 2019; 63(3):181-186. PubMed ID: 30914237
[TBL] [Abstract][Full Text] [Related]
31. Treatment and outcome of recurrent pelvic chondrosarcoma.
Weber KL; Pring ME; Sim FH
Clin Orthop Relat Res; 2002 Apr; (397):19-28. PubMed ID: 11953591
[TBL] [Abstract][Full Text] [Related]
32. Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.
Rutkowski P; Trepka S; Ptaszynski K; Kołodziejczyk M
Clin Orthop Relat Res; 2013 Mar; 471(3):860-70. PubMed ID: 22972658
[TBL] [Abstract][Full Text] [Related]
33. Chondrosarcoma of bone: does the size of the tumor, the presence of a pathologic fracture, or prior intervention have an impact on local control and survival?
Puri A; Shah M; Agarwal MG; Jambhekar NA; Basappa P
J Cancer Res Ther; 2009; 5(1):14-9. PubMed ID: 19293483
[TBL] [Abstract][Full Text] [Related]
34. Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery.
Sheth DS; Yasko AW; Johnson ME; Ayala AG; Murray JA; Romsdahl MM
Cancer; 1996 Aug; 78(4):745-50. PubMed ID: 8756367
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
36. An institutional review of clear cell chondrosarcoma.
Itälä A; Leerapun T; Inwards C; Collins M; Scully SP
Clin Orthop Relat Res; 2005 Nov; 440():209-12. PubMed ID: 16239809
[TBL] [Abstract][Full Text] [Related]
37. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity.
Cho WH; Song WS; Jeon DG; Kong CB; Koh JS; Kim JI; Lee SY
Ann Surg Oncol; 2011 Dec; 18(13):3755-61. PubMed ID: 21611858
[TBL] [Abstract][Full Text] [Related]
38. Gamma Knife surgery for intracranial chordoma and chondrosarcoma: radiosurgical perspectives and treatment outcomes.
Kim JH; Jung HH; Chang JH; Chang JW; Park YG; Chang WS
J Neurosurg; 2014 Dec; 121 Suppl():188-97. PubMed ID: 25434952
[TBL] [Abstract][Full Text] [Related]
39. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up.
Andreou D; Ruppin S; Fehlberg S; Pink D; Werner M; Tunn PU
Acta Orthop; 2011 Dec; 82(6):749-55. PubMed ID: 22066552
[TBL] [Abstract][Full Text] [Related]
40. Surgical treatment of low-grade chondrosarcoma involving the appendicular skeleton: long-term functional and oncological outcomes.
Shemesh SS; Pretell-Mazzini J; Quartin PAJ; Rutenberg TF; Conway SA
Arch Orthop Trauma Surg; 2019 Dec; 139(12):1659-1666. PubMed ID: 31020410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]